AstraZeneca Presents Tagrisso (osimertinib) Data in Patients with EGFR
Tagrisso extended the length of time patients with CNS metastases lived with...
2017-06-07
文传商讯
Encouraging Phase II survival data for nintedanib in malignant pleural
Oral nintedanib plus standard chemotherapy (pemetrexed/cisplatin) demonstrat...
2017-06-07
文传商讯
Lynparza (olaparib) Maintenance Treatment Offers Sustained Quality of L
Change in functional assessment of ovarian cancer therapy (FACT-O TOI) simil...
2017-06-05
文传商讯
IPF patients treated with OFEV (nintedanib) versus placebo were twice a
Separate subgroup analysis demonstrates long-term efficacy of OFEV in slowin...
2017-05-26
文传商讯
Boehringer Ingelheim Phase III study now enrolling patients with progre
For the first time, patients with different fibrosing lung diseases will be ...
2017-03-22
文传商讯
Uninterrupted Pradaxa Showed Less Major Bleeding than Warfarin in Atria
In the RE-CIRCUIT trial, there were less major bleeding and fewer serious ad...
2017-03-20
文传商讯
First dedicated outcome trials of empagliflozin in chronic heart failur
EMPEROR HF clinical trial programme will evaluate the efficacy and safety of...
2017-03-20
文传商讯
Oral OTEZLA (Apremilast) Demonstrated Significant Improvement versus Pl
Data from UNVEIL, the first trial of patients with moderate plaque psoriasis...
2017-03-06
文传商讯
Celgene to Present New Data from Clinical Trials on Oral OTEZLA (apremi
UNVEIL evaluated the efficacy and safety of oral OTEZLA at 16 weeks in patie...
2017-03-06
文传商讯
Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizum
Efficacy and safety of afatinib plus pembrolizumab to be assessed in Phase I...
2017-02-10
文传商讯
